Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark L Chiu

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Current Protocols in Protein Science|February 2, 2012
Introduction to membrane proteinsMark L Chiu
Current Opinion in Structural Biology|August 16, 2016
Engineering antibody therapeuticsMark L Chiu, Gary L Gilliland
The Journal of Biological Chemistry|November 19, 2016
Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 AntibodyDi Zhang, Monica V Goldberg, Mark L Chiu
Mabs|December 9, 2014
Raman spectroscopy characterization of antibody phases in serumAudrey E Baker, Amber R Mantz, Mark L Chiu
Current Protocols|June 26, 2023
Introduction to the Use of Linear and Nonlinear Regression Analysis in Quantitative Biological AssaysStephen W Jarantow, Eileen D Pisors, Mark L Chiu
Combinatorial Chemistry & High Throughput Screening|August 5, 2008
Over-expression, solubilization, and purification of G protein-coupled receptors for structural biologyMark L Chiu, Cindy Tsang, Nelson Grihalde, et al.
Mabs|January 24, 2018
FcγRII-binding Centyrins mediate agonism and antibody-dependent cellular phagocytosis when fused to an anti-OX40 antibodyDi Zhang, Brian Whitaker, Mehabaw G Derebe, et al.
Mabs|May 7, 2026
A novel insulin-like growth factor II-based masking domain for conditional activation of therapeutic antibodiesLihua Shi, Minseon Cho, Motohiko Nishida, et al.
Antibodies (Basel, Switzerland)|December 11, 2019
Antibody Structure and Function: The Basis for Engineering TherapeuticsMark L Chiu, Dennis R Goulet, Alexey Teplyakov, et al.
Bioconjugate Chemistry|February 26, 2015
High-throughput assay for measuring monoclonal antibody self-association and aggregation in serumXiaoning Li, Steven B Geng, Mark L Chiu, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Current Protocols in Protein Science|February 2, 2012
Introduction to membrane proteinsMark L Chiu
Current Opinion in Structural Biology|August 16, 2016
Engineering antibody therapeuticsMark L Chiu, Gary L Gilliland
The Journal of Biological Chemistry|November 19, 2016
Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 AntibodyDi Zhang, Monica V Goldberg, Mark L Chiu
Mabs|December 9, 2014
Raman spectroscopy characterization of antibody phases in serumAudrey E Baker, Amber R Mantz, Mark L Chiu
Current Protocols|June 26, 2023
Introduction to the Use of Linear and Nonlinear Regression Analysis in Quantitative Biological AssaysStephen W Jarantow, Eileen D Pisors, Mark L Chiu
Combinatorial Chemistry & High Throughput Screening|August 5, 2008
Over-expression, solubilization, and purification of G protein-coupled receptors for structural biologyMark L Chiu, Cindy Tsang, Nelson Grihalde, et al.
Mabs|January 24, 2018
FcγRII-binding Centyrins mediate agonism and antibody-dependent cellular phagocytosis when fused to an anti-OX40 antibodyDi Zhang, Brian Whitaker, Mehabaw G Derebe, et al.
Mabs|May 7, 2026
A novel insulin-like growth factor II-based masking domain for conditional activation of therapeutic antibodiesLihua Shi, Minseon Cho, Motohiko Nishida, et al.
Antibodies (Basel, Switzerland)|December 11, 2019
Antibody Structure and Function: The Basis for Engineering TherapeuticsMark L Chiu, Dennis R Goulet, Alexey Teplyakov, et al.
Bioconjugate Chemistry|February 26, 2015
High-throughput assay for measuring monoclonal antibody self-association and aggregation in serumXiaoning Li, Steven B Geng, Mark L Chiu, et al.
Pageof 5